Generic, proprietary drug manufacturers square off in patent extension debate.
- Published in:
- Formulary, 1996, v. 31, n. 6, p. 534
- By:
- Publication type:
- Article
Works matching IS 1082801X AND DT 1996 AND VI 31 AND IP 6
Results: 10
1
2
Abstracts.
- Published in:
- 1996
- Publication type:
- Abstract
3
Meeting highlights.
- Published in:
- Formulary, 1996, v. 31, n. 6, p. 519
- Publication type:
- Article
4
How to target adverse drug events using cost-benefit analysis.
- Published in:
- Formulary, 1996, v. 31, n. 6, p. 507
- By:
- Publication type:
- Article
5
Consolidating P & T Committees in an integrated health care system.
- Published in:
- Formulary, 1996, v. 31, n. 6, p. 497
- By:
- Publication type:
- Article
6
Opportunistic infections in patients with AIDS: Treatment and prophylaxis.
- Published in:
- Formulary, 1996, v. 31, n. 6, p. 470
- By:
- Publication type:
- Article
7
FDA news and product notes.
- Published in:
- Formulary, 1996, v. 31, n. 6, p. 444
- Publication type:
- Article
8
News capsules.
- Published in:
- Formulary, 1996, v. 31, n. 6, p. 439
- Publication type:
- Article
9
The clinical relevance of penicillin-resistant Streptococcus pneumoniae.
- Published in:
- 1996
- By:
- Publication type:
- Editorial
10
Focus on mirtazapine: A new antidepressant with noradrenergic and specific serotonergic activity.
- Published in:
- Formulary, 1996, v. 31, n. 6, p. 455
- By:
- Publication type:
- Article